Genetic alterations in hormone-refractory recurrent prostate carcinomas.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Pathology

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)65554-XPMID 9665474PMCID PMC1852946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

  1998cited by this paper
• Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

  1997cited by this paper
• Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

  1997cited by this paper
• Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

  1997cited by this paper
• BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.

  1997cited by this paper
• Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

  1997cited by this paper
• Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q

  1997cited by this paper
• Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.

  1997cited by this paper
• The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma.

  1996cited by this paper
• Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

  1996cited by this paper
• REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma.

  1996cited by this paper
• The Glial and Mesenchymal Elements of Gliosarcomas Share Similar Genetic Alterations

  1996cited by this paper
• Proteins of the Myc network: essential regulators of cell growth and differentiation.

  1996cited by this paper
• Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

  1996cited by this paper
• Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

  1996cited by this paper
• Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.

  1996cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

  1995cited by this paper
• Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization

  1995cited by this paper
• Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

  1995cited by this paper
• In vivo amplification of the androgen receptor gene and progression of human prostate cancer

  1995cited by this paper
• DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.

  1995cited by this paper
• Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).

  1995cited by this paper
• Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.

  1995cited by this paper
• Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.

  1995cited by this paper
• Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.

  1995cited by this paper
• Mutation of the MXI1 gene in prostate cancer

  1995cited by this paper
• Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization

  1995cited by this paper
• Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

  1995cited by this paper
• Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

  1994cited by this paper
• Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.

  1994cited by this paper
• Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.

  1994cited by this paper
• Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

  1994cited by this paper
• DNA amplification: New insights into its mechanism

  1994cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer

  1994cited by this paper
• Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

  1994cited by this paper
• Allelic loss in locally metastatic, multisampled prostate cancer.

  1994cited by this paper
• Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.

  1994cited by this paper
• Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.

  1994cited by this paper
• Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

  1993cited by this paper
• Gene amplification and tumor progression.

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

  1993cited by this paper
• Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization

  1993cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Prostate cancer: therapeutic, diagnostic, and basic studies.

  1992cited by this paper
• Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

  1992cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas

  1992cited by this paper
• Allelotyping of human prostatic adenocarcinoma.

  1991cited by this paper
• DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.

  1991cited by this paper
• Allelic loss of chromosomes 16q and 10q in human prostate cancer.

  1990cited by this paper
• Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers

  1988cited by this paper
• Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia.

  1986cited by this paper

• Upstream Stimulatory Factor 2 Protects Cardiomyocytes by Regulating Mitochondrial Homeostasis.

  2025cites this paper
• Investigating the Impact of the Secretome From hAMSCs on HT‐29 Colon Cancer Cells via TNF‐α/TGF‐β/c‐MYC Signaling Pathways Using a Three‐Dimensional Cell Culture Model

  2025cites this paper
• Significance of PSCA as a novel prognostic marker and therapeutic target for cancer

  2024cites this paper
• Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia

  2023cites this paper
• Cancer Stem Cells and Prostate Cancer: A Narrative Review

  2023cites this paper
• Insights into the mechanism of binding of doxorubicin and a chlorin compound with 22-mer c-Myc G quadruplex.

  2023cites this paper
• Variability of Inverted Repeats in All Available Genomes of Bacteria

  2023cites this paper
• Differences in SUV39H1 and androgen receptor distribution in adenomyomatous hyperplasia and prostatic adenocarcinoma

  2022cites this paper
• Resistance to the Androgen Receptor Centred Therapies: Biology and Management

  2021cites this paper
• Structural recognition of the MYC promoter G-quadruplex by a quinoline derivative: insights into molecular targeting of parallel G-quadruplexes

  2021cites this paper
• Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies

  2021cites this paper
• Loss of USF2 promotes proliferation, migration and mitophagy in a redox-dependent manner

  2020cites this paper
• Caveola-forming proteins and prostate cancer

  2020cites this paper
• A piece in prostate cancer puzzle: Future perspective of novel molecular signatures

  2020influential citation
• Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments

  2020cites this paper
• Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC

  2020cites this paper
• Prognostic Significance of High Androgen Receptor Expression in Prostatic Acinar Adenocarcinoma

  2019cites this paper
• Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer.

  2019cites this paper
• Prostate cancer.

  2019cites this paper
• Structures of 1:1 and 2:1 complexes of BMVC and MYC promoter G-quadruplex reveal a mechanism of ligand conformation adjustment for G4-recognition

  2019cites this paper
• Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.

  2019cites this paper
• Molecular Carcinogenesis

  2019cites this paper
• Evaluation of c-Myc mRNA Expression Level in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Tissues and Its Correlation with Clinicopathological Characteristics

  2018cites this paper
• c-Myc regulates the CDK1/cyclin B1 dependent-G2/M cell cycle progression by histone H4 acetylation in Raji cells

  2018cites this paper
• Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.

  2018cites this paper
• Review on Gene Therapy of Prostate Cancer

  2018cites this paper
• O‐Glycosylation‐mediated signaling circuit drives metastatic castration‐resistant prostate cancer

  2018influential citation
• Eukaryotic translation initiation factor 3H suppression inhibits osteocarcinoma cell growth and tumorigenesis

  2018cites this paper
• c-Myc regulates the CDK1/cyclin B1 dependent-G2/M cell cycle progression by histone H4 acetylation in Raji cells

  2018cites this paper
• INTEGRATIVE BIOINFORMATICS APPROACHES TO ELUCIDATING PROSTATE CANCER CELL HETEROGENEITY, PLASTICITY, AND TREATMENT RESPONSE

  2018cites this paper
• Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression

  2017cites this paper
• Prostate Cancer Metastasis

  2017cites this paper
• Targeting MCT4 for treatment of advanced prostate cancers : inhibiting cell proliferation and enhancing anticancer immunity through suppressing lactic acid secretion and elevated glycolysis

  2017cites this paper
• In vitro pro-apoptotic and anti-migratory effects of Marantodes pumilum (Blume) Kuntze and Ficus deltoidea L. extracts on prostate cancer cell lines

  2017cites this paper
• Telomeres and telomerase in prostate cancer development and therapy

  2017cites this paper
• Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer

  2017cites this paper
• NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer

  2016influential citation
• Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells

  2016cites this paper
• Conventional and Promising Biomarkers for Prostate Cancer their Clinical Implication and Prospective Role

  2016cites this paper
• HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

  2016cites this paper
• Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism

  2015cites this paper
• Influencia del consumo de antiinflamatorios no esteroideos en la incidencia de cáncer de mama: = Influence of non-streroidal antiinflammatory drugs use on breast cancer incidence

  2015cites this paper
• Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer

  2015cites this paper
• Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression

  2015cites this paper
• Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer

  2015cites this paper
• The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo

  2015cites this paper
• GSK3β-Dependent Phosphorylation Alters DNA Binding, Transactivity and Half-Life of the Transcription Factor USF2

  2014cites this paper
• 504: Functional proteomic analysis of leukaemogenic protein tyrosine kinase targets

  2014cites this paper
• Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression

  2014cites this paper
• The role of osteoprotegerin and receptor activator of nuclear factor ᴋb in osteotropic prostate and breast cancers

  2014cites this paper
• Array comparative genomic hybridization analysis identified the chromosomal aberrations and putative genes involved in prostate tumorigenesis of Malaysian men

  2014cites this paper
• Androgen receptor phosphorylation in prostate diseases

  2014cites this paper
• Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications

  2014cites this paper
• Differential gene expression analysis and genetic association studies in benign and malignant prostate tissues

  2014cites this paper
• Nucleic acid-based tissue biomarkers of urologic malignancies

  2014cites this paper
• Insights of potential G-quadruplex sequences in telomeres and proto-oncogenes

  2013cites this paper
• Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells

  2013cites this paper
• Molecular Pathways in Prostate Cancer

  2013cites this paper
• The Role of Autophagy and Translation Initiation Factors in Overcoming Resistance to mTOR Inhibitors in Prostate Cancer.

  2013cites this paper
• Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

  2013cites this paper
• Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development

  2013cites this paper
• Molecular pathogenesis and progression of prostate cancer.

  2013cites this paper
• The Role of MYC Rearrangements and Relative Copy Number Gain in Prostate Cancer

  2013influential citation
• Progress towards determining the structure of the smallest active pectin that induces apoptosis in vitro

  2013cites this paper
• The detection of TMPRSS2:ERG fusion gene in blood of prostate cancer patients

  2012cites this paper
• Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration‐resistant prostate cancer

  2012cites this paper
• Molecular Analysis of Desmoid Tumors with a High-Density Single-Nucleotide Polymorphism Array Identifies New Molecular Candidate Lesions

  2012cites this paper
• Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges

  2012cites this paper
• Overexpression of Androgen Receptor in Prostate Cancer

  2012cites this paper
• Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen‐deprivation therapy

  2012cites this paper
• Local and Distant Effects of Caveolin-1 on Prostate Cancer Progression

  2012cites this paper
• The role of 8q amplification and microRNAs in prostate cancer

  2012cites this paper
• Prognostic relevance of Bcl‐2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene

  2012cites this paper
• miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression.

  2011cites this paper
• Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan.

  2011cites this paper
• Meta‐analysis of genome‐wide and replication association studies on prostate cancer

  2011cites this paper
• Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.

  2011cites this paper
• Micro RNA em adenocarcinoma de próstata: caracterização da expressão em tumores de baixo grau, órgão-confinados

  2011cites this paper
• MicroRNAs Associated with Metastatic Prostate Cancer

  2011cites this paper
• Prostate and Colon Cancer Stem Cells as a Target for Anti-Cancer Drug Development

  2011cites this paper
• Androgen Receptor Regulation of Prostate Cancer Progression and Metastasis

  2011cites this paper
• Regulation of the prostate-specific hTGP (TGM4) gene and its potential use for prostate cancer gene therapy

  2011cites this paper
• PMEPA1 promotes androgen receptor‐negative prostate cell proliferation through suppressing the Smad3/4–c‐Myc–p21$^{{\rm Cip1}}$ signaling pathway

  2011cites this paper
• c-MYC promoter G-quadruplex formed at the 5′-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability

  2011cites this paper
• Nukleäre p53-Akkumulation und Marker der genetischen Instabilität beim Prostatakarzinom

  2011influential citation
• Susceptibilidad genética al cáncer de tiroides: estudios de asociación de las regiones del genoma 1p12 y 8q

  2011influential citation
• High-Throughput Screening for Novel Prostate Cancer Drug Targets –Getting Personal

  2011cites this paper
• Common Variants of the Thyroglobulin Gene Are Associated with Differentiated Thyroid Cancer Risk

  2011cites this paper
• The role of caveolin-1 in human breast cancer

  2011cites this paper
• Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

  2011cites this paper
• The Prostate 71 : 209 ^ 224 ( 2011 ) Meta-Analysis ofGenome-Wide andReplication Association Studies on ProstateCancer

  2010cites this paper
• Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer

  2010cites this paper
• Animal models of choroidal and retinal neovascularization.

  2010cites this paper
• Structural insights into G-quadruplexes: towards new anticancer drugs.

  2010cites this paper
• Thermodynamic stability and folding kinetics of the major G-quadruplex and its loop isomers formed in the nuclease hypersensitive element in the human c-Myc promoter: effect of loops and flanking segments on the stability of parallel-stranded intramolecular G-quadruplexes.

  2010cites this paper
• MicroRNAs and prostate cancer.

  2010cites this paper
• Expression of prostate stem cell antigen in high‐grade prostatic intraepithelial neoplasia and prostate cancer

  2010cites this paper
• MYC and Prostate Cancer.

  2010cites this paper
• [PC-1 enhances c-myc gene expression in prostate cancer cells].

  2010cites this paper
• ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer

  2010cites this paper